BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27612420)

  • 1. ATAD2 is an epigenetic reader of newly synthesized histone marks during DNA replication.
    Koo SJ; Fernández-Montalván AE; Badock V; Ott CJ; Holton SJ; von Ahsen O; Toedling J; Vittori S; Bradner JE; Gorjánácz M
    Oncotarget; 2016 Oct; 7(43):70323-70335. PubMed ID: 27612420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutual Balance of Histone Deacetylases 1 and 2 and the Acetyl Reader ATAD2 Regulates the Level of Acetylation of Histone H4 on Nascent Chromatin of Human Cells.
    Lazarchuk P; Hernandez-Villanueva J; Pavlova MN; Federation A; MacCoss M; Sidorova JM
    Mol Cell Biol; 2020 Apr; 40(9):. PubMed ID: 32015101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordination of Di-Acetylated Histone Ligands by the ATAD2 Bromodomain.
    Evans CM; Phillips M; Malone KL; Tonelli M; Cornilescu G; Cornilescu C; Holton SJ; Gorjánácz M; Wang L; Carlson S; Gay JC; Nix JC; Demeler B; Markley JL; Glass KC
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological function and histone recognition of family IV bromodomain-containing proteins.
    Lloyd JT; Glass KC
    J Cell Physiol; 2018 Mar; 233(3):1877-1886. PubMed ID: 28500727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ATAD2 bromodomain binds different acetylation marks on the histone H4 in similar fuzzy complexes.
    Langini C; Caflisch A; Vitalis A
    J Biol Chem; 2017 Oct; 292(40):16734-16745. PubMed ID: 28798233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disulfide bridge formation influences ligand recognition by the ATAD2 bromodomain.
    Gay JC; Eckenroth BE; Evans CM; Langini C; Carlson S; Lloyd JT; Caflisch A; Glass KC
    Proteins; 2019 Feb; 87(2):157-167. PubMed ID: 30520161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Combinatorial Histone Modifications on Acetyllysine Recognition by the ATAD2 and ATAD2B Bromodomains.
    Phillips M; Malone KL; Boyle BW; Montgomery C; Kressy IA; Joseph FM; Bright KM; Boyson SP; Chang S; Nix JC; Young NL; Jeffers V; Frietze S; Glass KC
    J Med Chem; 2024 May; 67(10):8186-8200. PubMed ID: 38733345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atad2 is a generalist facilitator of chromatin dynamics in embryonic stem cells.
    Morozumi Y; Boussouar F; Tan M; Chaikuad A; Jamshidikia M; Colak G; He H; Nie L; Petosa C; de Dieuleveult M; Curtet S; Vitte AL; Rabatel C; Debernardi A; Cosset FL; Verhoeyen E; Emadali A; Schweifer N; Gianni D; Gut M; Guardiola P; Rousseaux S; Gérard M; Knapp S; Zhao Y; Khochbin S
    J Mol Cell Biol; 2016 Aug; 8(4):349-62. PubMed ID: 26459632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolysis of a histone acetyl reader, ATAD2, induces chemoresistance of cancer cells under severe hypoxia by inhibiting cell cycle progression in S phase.
    Haitani T; Kobayashi M; Koyasu S; Akamatsu S; Suwa T; Onodera Y; Nam JM; Nguyen PTL; Menju T; Date H; Ogawa O; Harada H
    Cancer Lett; 2022 Mar; 528():76-84. PubMed ID: 34973392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the human ATAD2 AAA+ histone chaperone reveals mechanism of regulation and inter-subunit communication.
    Cho C; Ganser C; Uchihashi T; Kato K; Song JJ
    Commun Biol; 2023 Sep; 6(1):993. PubMed ID: 37770645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-Promoting ATAD2 and Its Preclinical Challenges.
    Liu H; Wen Q; Yan S; Zeng W; Zou Y; Liu Q; Zhang G; Zou J; Zou X
    Biomolecules; 2022 Jul; 12(8):. PubMed ID: 36008934
    [No Abstract]   [Full Text] [Related]  

  • 12. Chromatin loading of E2F-MLL complex by cancer-associated coregulator ANCCA via reading a specific histone mark.
    Revenko AS; Kalashnikova EV; Gemo AT; Zou JX; Chen HW
    Mol Cell Biol; 2010 Nov; 30(22):5260-72. PubMed ID: 20855524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging oncogene ATAD2: Signaling cascades and therapeutic initiatives.
    Nayak A; Dutta M; Roychowdhury A
    Life Sci; 2021 Jul; 276():119322. PubMed ID: 33711386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATPase family AAA domain-containing protein 2 (ATAD2): From an epigenetic modulator to cancer therapeutic target.
    Fu J; Zhang J; Chen X; Liu Z; Yang X; He Z; Hao Y; Liu B; Yao D
    Theranostics; 2023; 13(2):787-809. PubMed ID: 36632213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant genome reprogramming by ATAD2.
    Boussouar F; Jamshidikia M; Morozumi Y; Rousseaux S; Khochbin S
    Biochim Biophys Acta; 2013 Oct; 1829(10):1010-4. PubMed ID: 23831842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Insights into the Recognition of Mono- and Diacetylated Histones by the ATAD2B Bromodomain.
    Lloyd JT; McLaughlin K; Lubula MY; Gay JC; Dest A; Gao C; Phillips M; Tonelli M; Cornilescu G; Marunde MR; Evans CM; Boyson SP; Carlson S; Keogh MC; Markley JL; Frietze S; Glass KC
    J Med Chem; 2020 Nov; 63(21):12799-12813. PubMed ID: 33084328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoform-Selective ATAD2 Chemical Probe with Novel Chemical Structure and Unusual Mode of Action.
    Fernández-Montalván AE; Berger M; Kuropka B; Koo SJ; Badock V; Weiske J; Puetter V; Holton SJ; Stöckigt D; Ter Laak A; Centrella PA; Clark MA; Dumelin CE; Sigel EA; Soutter HH; Troast DM; Zhang Y; Cuozzo JW; Keefe AD; Roche D; Rodeschini V; Chaikuad A; Díaz-Sáez L; Bennett JM; Fedorov O; Huber KVM; Hübner J; Weinmann H; Hartung IV; Gorjánácz M
    ACS Chem Biol; 2017 Nov; 12(11):2730-2736. PubMed ID: 29043777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observed bromodomain flexibility reveals histone peptide- and small molecule ligand-compatible forms of ATAD2.
    Poncet-Montange G; Zhan Y; Bardenhagen JP; Petrocchi A; Leo E; Shi X; Lee GR; Leonard PG; Geck Do MK; Cardozo MG; Andersen JN; Palmer WS; Jones P; Ladbury JE
    Biochem J; 2015 Mar; 466(2):337-46. PubMed ID: 25486442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone H4 acetylation and the epigenetic reader Brd4 are critical regulators of pluripotency in embryonic stem cells.
    Gonzales-Cope M; Sidoli S; Bhanu NV; Won KJ; Garcia BA
    BMC Genomics; 2016 Feb; 17():95. PubMed ID: 26847871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatin dynamics during DNA replication.
    Bar-Ziv R; Voichek Y; Barkai N
    Genome Res; 2016 Sep; 26(9):1245-56. PubMed ID: 27225843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.